GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Anteris Technologies Ltd (OTCPK:AMEUF) » Definitions » EV-to-FCF

Anteris Technologies (Anteris Technologies) EV-to-FCF : -6.34 (As of May. 21, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Anteris Technologies EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Anteris Technologies's Enterprise Value is $233.58 Mil. Anteris Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $-36.86 Mil. Therefore, Anteris Technologies's EV-to-FCF for today is -6.34.

The historical rank and industry rank for Anteris Technologies's EV-to-FCF or its related term are showing as below:

AMEUF' s EV-to-FCF Range Over the Past 10 Years
Min: -41.79   Med: -4.13   Max: 0.06
Current: -6.34

During the past 13 years, the highest EV-to-FCF of Anteris Technologies was 0.06. The lowest was -41.79. And the median was -4.13.

AMEUF's EV-to-FCF is ranked worse than
100% of 361 companies
in the Medical Devices & Instruments industry
Industry Median: 28.3 vs AMEUF: -6.34

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-21), Anteris Technologies's stock price is $13.15. Anteris Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-2.888. Therefore, Anteris Technologies's PE Ratio for today is At Loss.


Anteris Technologies EV-to-FCF Historical Data

The historical data trend for Anteris Technologies's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anteris Technologies EV-to-FCF Chart

Anteris Technologies Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.30 -1.55 -6.55 -7.15 -5.69

Anteris Technologies Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.55 - -7.15 - -5.69

Competitive Comparison of Anteris Technologies's EV-to-FCF

For the Medical Devices subindustry, Anteris Technologies's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anteris Technologies's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Anteris Technologies's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Anteris Technologies's EV-to-FCF falls into.



Anteris Technologies EV-to-FCF Calculation

Anteris Technologies's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=233.575/-36.859
=-6.34

Anteris Technologies's current Enterprise Value is $233.58 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Anteris Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $-36.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anteris Technologies  (OTCPK:AMEUF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Anteris Technologies's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=13.15/-2.888
=At Loss

Anteris Technologies's share price for today is $13.15.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Anteris Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-2.888.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Anteris Technologies EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Anteris Technologies's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Anteris Technologies (Anteris Technologies) Business Description

Traded in Other Exchanges
Address
Level 3, 9 Sherwood Road, Suite 302, Toowong Tower, Toowong, QLD, AUS, 4066
Anteris Technologies Ltd is a structural heart company engaged in delivering clinically superior solutions that help healthcare professionals create life-changing outcomes for patients. The group's solutions include Anteris' DurAVR transcatheter heart valve for younger patients who need a heart valve that will last their lifetime, as well as DurAVR with its biomimetic design that replicates the normal blood flow of a healthy human aortic valve. The company derives key revenue from Australia and the U.S.